Home

Lancope drives specialised threat analysis and protection market

LONDON (UK): Lancope, Inc. is already achieving significant corporate momentum in 2015 as it helps drive the market for advanced security analytics and continuous response. By collecting and analysing vast amounts of data from across an enterprise’s entire network, Lancope’s StealthWatch® System enables organisations to obtain in-depth security context for fighting off today’s most damaging cyber threats. Actionable security intelligence allows organisations to move away from ineffective perimeter-based defenses and embrace a more comprehensive, continuous strategy for incident response.HIHI

: LARA LACKIE; Industry News; Posted On Monday, 02 March 2015 09:31

Growing passenger volumes and advanced threats spur global airport security technology market

LONDON: Effective security technologies and systems are still in demand among airport operators as increasing passenger volumes place new strains on existing infrastructure. The unrelenting threat of terrorism and crime plaguing the global landscape leave airport operators with no choice but to invest in robust security technologies. While the mature European and North American airport security technology markets will witness incremental growth, markets in the developing regions will undergo a more substantial uptrend.

: Edyta Grabowska; Transport and Technology; Posted On Friday, 27 February 2015 05:24

BSIA members report business benefits of record-breaking Intersec 2015

The Intersec exhibition held in Dubai last month is fast becoming a must-attend event for British security providers. Members of the British Security Industry Association (BSIA) and its Export Council, who were there in force for the 17th year, report a high level of interest in the wide range of innovative UK security solutions, from integrated systems to access control, CCTV, perimeter protection, intruder alarm and power supply technology, on display. The scale of the British presence at Intersec 2015 was certainly impressive this time around, with the BSIA-organised UK Pavilion the focal point of the highest-ever turnout of UK companies.

: John Aduma; The BSIA Page; Posted On Friday, 27 February 2015 05:19

Aethlon Medical announces first patient completes Hemopurifier clinical study protocol

SAN DIEGO: Aethlon Medical, Inc. (OTCBB:AEMD) has announced that the first patient enrolled in the Company's FDA approved feasibility study has completed their full Hemopurifier® treatment protocol without any device-related adverse events. The study protocol, which is being administered at DaVita Med Center Dialysis in Houston, is enrolling ten chronic dialysis patients infected with Hepatitis C virus (HCV) to receive a six treatment protocol of Hemopurifier therapy. The Aethlon Hemopurifier is a first-in-class bio-filtration device that provides the broad-spectrum elimination of infectious viruses from the circulatory system of infected individuals.